Date of publication: 02 February 2011
Publication type: Systematic review
In a nutshell: This review incorporates a randomized control trial and to look at the risk of fatal adverse events associated with the use of Bevacizumab during chemotherapy. The findings indicate that there is an increased likelihood of fatal adverse events for patients being treated with the drug.
Length of publication: 7 web pages
Some important information: Please contact your local NHS Library for the full text of the article. Follow this link to find your local NHS Library.